Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

for
Healthy Subject, Hematologic and Lymphocytic Disorder,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 19+

Code: NCT03207854

Recruiting

Ultralow Dose PET Imaging of 18F-FDG Uptake

for
Healthy Volunteer, Cancer
Location: Englewood NJ
Sponsor: Akiva Mintz

Sex: All

Age: 18 - 70+

Code: NCT06956391

Phase 2, Recruiting

Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults

for
Cigarette Smoking-Related Carcinoma
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 21+

Code: NCT06816459

Early Phase 1, Recruiting

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Boston MA, Philadelphia PA, Arlington VA, Fairfield OH,
Sponsor: BicycleTx Limited

Sex: All

Age: 18+

Code: NCT06933329

Phase 2, Recruiting

A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07126496

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

for
Cigarette Smoking-Related Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06145763

Recruiting

Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.

for
Sarcoid, Cardiovascular Diseases, Cancer
Location: Boston MA
Sponsor: Ralph Weissleder, MD

Sex: All

Age: 18 - 70+

Code: NCT04843891

Phase 1, Recruiting

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

for
Malignant Solid Tumors
Location: New York NY, Montvale NJ
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 21 - 70+

Code: NCT02421380

Recruiting

Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes

for
Hereditary Malignant Neoplasm, Hereditary Neoplastic Syndrome
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT06927947

Recruiting

Breast Cancer Liquid Biopsy Trial

for
Breast Cancer, Cancer
Location: Bronx NY, New York NY, Hollywood FL, Orlando FL,
Sponsor: Anthony Magliocco

Sex: All

Age: 18+

Code: NCT04962529

Recruiting

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

for
Cancer
Location: Edmonton, Red Deer, Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07024329

Recruiting

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

for
Cancer, Childhood Cancer,
Location: New Haven CT, Trumbull CT
Sponsor: Yale University

Sex: All

Age: 5+

Code: NCT07019259

Recruiting

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

for
Solid Tumor
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 1 - 70

Code: NCT05238792

Phase 1, Recruiting

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

for
Leukemia, Relapsed Leukemia, Chronic Lymphocytic Leukemia,
Location: Boston MA
Sponsor: Jennifer R. Brown, MD, PhD

Sex: All

Age: 18+

Code: NCT06644183

Phase 1, Phase 2, Recruiting

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for
Malignant Neoplasm
Location: Sherbrooke, New York NY, Hackensack NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06979596

Phase 2, Recruiting

Ovarian Tissue Freezing For Fertility Preservation

for
Malignancy, Fertility
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: Female

Age: 18 - 41

Code: NCT00902720

Recruiting

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

for
Sinonasal Neuroendocrine Carcinoma, Nasopharyngeal Carcinoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06479811

Phase 1, Recruiting

Clinical and Genetic Studies of Li-Fraumeni Syndrome

for
Li-Fraumeni Syndrome, Neoplasms, Tp53 Mutations
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT01443468

Recruiting

Implementation of an Oral Chemotherapy Adherence Intervention

for
Solid Tumor, Hematologic Malignancy
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 21+

Code: NCT06989489

Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Raleigh NC, Tampa FL, Detroit MI, St Louis MO,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase 1, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial